Lipid lowering drugs and hyperlipidaemia.
D001692:Biological Transport; D002675:Child, Preschool; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002914:Chylomicrons / Q000378:metabolism; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D007231:Infant, Newborn; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008954:Models, Biological; D009539:Nicotinic Acids / Q000627:therapeutic use; D010743:Phospholipids / Q000097:blood; D013974:Thyroxine / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D002914:Chylomicrons; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D009539:Nicotinic Acids; D010743:Phospholipids; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol; D002994:Clofibrate; D013974:Thyroxine